BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23066114)

  • 1. Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes.
    Ngeow J; He X; Mester JL; Lei J; Romigh T; Orloff MS; Milas M; Eng C
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2320-7. PubMed ID: 23066114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer.
    Ngeow J; Ni Y; Tohme R; Song Chen F; Bebek G; Eng C
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1316-21. PubMed ID: 24712574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
    Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
    He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study.
    Mahdi H; Mester JL; Nizialek EA; Ngeow J; Michener C; Eng C
    Cancer; 2015 Mar; 121(5):688-96. PubMed ID: 25376524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53.
    Ni Y; He X; Chen J; Moline J; Mester J; Orloff MS; Ringel MD; Eng C
    Hum Mol Genet; 2012 Jan; 21(2):300-10. PubMed ID: 21979946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes.
    Ni Y; Zbuk KM; Sadler T; Patocs A; Lobo G; Edelman E; Platzer P; Orloff MS; Waite KA; Eng C
    Am J Hum Genet; 2008 Aug; 83(2):261-8. PubMed ID: 18678321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.
    Bennett KL; Mester J; Eng C
    JAMA; 2010 Dec; 304(24):2724-31. PubMed ID: 21177507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
    Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
    PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation.
    Yu W; He X; Ni Y; Ngeow J; Eng C
    Hum Mol Genet; 2015 Jan; 24(1):142-53. PubMed ID: 25149476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome.
    Barletta JA; Bellizzi AM; Hornick JL
    Am J Surg Pathol; 2011 Oct; 35(10):1505-11. PubMed ID: 21921783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells.
    Yu W; Ni Y; Saji M; Ringel MD; Jaini R; Eng C
    Hum Mol Genet; 2017 Apr; 26(7):1365-1375. PubMed ID: 28164237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation of the PTEN gene in a Japanese patient with Cowden syndrome and bilateral breast cancer.
    Tate G; Suzuki T; Endo Y; Mitsuya T
    Cancer Genet Cytogenet; 2008 Jul; 184(1):67-71. PubMed ID: 18558293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Cowden syndrome patient with a novel PTEN mutation and establishment of patient-derived induced pluripotent stem cells.
    Obayashi F; Hamada A; Yamasaki S; Kanda T; Toratani S; Okamoto T
    In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):69-78. PubMed ID: 34984555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
    Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
    Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilizing PTEN immunohistochemistry as a screening test for Cowden syndrome.
    Hartsough E; DeSimone MS; Lorenzo ME; Dias-Santagata D; Nose V; Hoang MP
    Am J Clin Pathol; 2024 May; 161(5):490-500. PubMed ID: 38206110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
    Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
    J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid Follicular Cell-derived Carcinomas in a Background of Multiple Adenomatous Nodules Leading to a Diagnosis of
    Liu A; Borges PM; Tay YS; Thompson LDR; Kong MX; Lai J
    Anticancer Res; 2022 Mar; 42(3):1481-1485. PubMed ID: 35220242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
    Fackenthal JD; Marsh DJ; Richardson AL; Cummings SA; Eng C; Robinson BG; Olopade OI
    J Med Genet; 2001 Mar; 38(3):159-64. PubMed ID: 11238682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands.
    Tan MH; Mester J; Peterson C; Yang Y; Chen JL; Rybicki LA; Milas K; Pederson H; Remzi B; Orloff MS; Eng C
    Am J Hum Genet; 2011 Jan; 88(1):42-56. PubMed ID: 21194675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.